MyChesCo on MSN4d
Endo, Inc. Shares Positive Data on XIAFLEX Treatment for Peyronie’s Disease
Endo, Inc. (OTCQX: NDOI) revealed new insights from a post hoc data analysis of its Phase 3 clinical trial of XIAFLEX® ...
The Brighterside of News on MSN1mon
Fish guts could be the future of skin care products
Among them, several stood out for their effects on enzymes linked to skin health: tyrosinase, responsible for melanin production, and collagenase, which degrades collagen. Collagenase contributes to ...
Medical Dialogues9d
Collagenase Injection More Effective Than Needle Fasciotomy for Primary Dupuytren Contracture: study
Collagenase Clostridium histolyticum (CCH) and percutaneous needle fasciotomy (PNF) are two treatment options for Dupuytren ...
Medscape26d
Collagenase Ointment Application at 24- Versus 48-Hour Intervals in the Treatment of Pressure Ulcers: A Randomized Multicenter Study
Objective: The purpose of the present study was to demonstrate clinical equivalence between the application of collagenase ointment at 24- and 48-hour intervals in the healing of pressure ulcers.
Physician's Weekly2d
Improved DNA recovery and STR profile development from weathered Bos taurus bones using demineralized bone slices.
Current processing techniques for harvesting DNA from osseous elements are destructive, and success rates vary widely. When skeletal elements are homogenized into a fine powder, endogenous DNA may be ...
Endo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association
Endo, Inc. (OTCQX: NDOI) announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or CCH) in patients with Peyronie's disease (PD) ...